Having marked its 100th anniversary in 2025, the business has successfully expanded globally, with ten distribution offices in strategic locations. In 2017, Tuttnauer entered a new era of accelerated global growth following its acquisition by Fortissimo Capital, a private equity firm that continues to support the company’s strategic expansion and operational advancement.
Today, Tuttnauer manufactures sterilization devices for the medical, dental, laboratory, and veterinary markets, supplying machines for customers from large hospitals or university research facilities to small clinics and private laboratories. With a newly appointed CEO, Hagay Azani, in place, Tuttnauer’s global growth shows no signs of slowing. We speak with Hagay to explore his vision for advancing the company and delivering a renewed customer experience.
“Our product range is one of our leading points of differentiation, as there are no other competitors in our field that can provide the breadth of autoclave and disinfector product range that we offer,” Hagay opens. “Our portfolio of products includes not only autoclaves but also washer-disinfectors and testing and validation consumables. In addition, we provide comprehensive turnkey solutions, including equipment planning, design, and installation, as well as consultation and feasibility studies for projects of all sizes.
“We are known for our forward-thinking approach to innovation and continued investment in manufacturing technology and software,” he continues. “In the last few years, we’ve implemented advanced robotic manufacturing, using sophisticated technology to enhance efficiency and reduce lead times.”
In 2023, Tuttnauer launched T-Connect, a groundbreaking software platform for smart clinics and laboratories seeking to leverage advanced technology to improve workflow efficiency and results. “T-Connect enables paperless documentation for our end users and provides real-time device diagnostics and troubleshooting, empowering users with intelligent data and greater control over their sterilization processes,” Hagay explains. “Many of our customers tell us how much T-Connect has improved their clinics in terms of maintenance and troubleshooting Tuttnauer devices. One of the most difficult challenges a hospital or healthcare facility can face is if a sterilization device malfunctions or needs repair interrupting their workflow process. T-Connect is designed to minimize downtime and ensure a higher standard of reliability.”
Success and longevity
With 2025 marking the company’s 100th anniversary, we ask Hagay to share his thoughts on the story behind such success and longevity. “Reaching 100 years in business is far more than a symbolic achievement, but rather represents a legacy of expertise, trust, and partnership,” he states. “Our strength comes from doing what we know best. For a century, we have remained dedicated to manufacturing autoclaves that are both premium and reliable; and that focus has never wavered. We’ve simply manufactured and sold sterilization devices for a century. Our production and service teams are among the most experienced in the industry, and many of our employees have been part of the Tuttnauer family for decades. Our teams have a tremendous dedication to this company, and their deep knowledge and commitment are simply invaluable. Such industry expertise has enabled us to build deep, longstanding relationships with many of our distribution partners, and we have grown successfully together over the decades.”
Considering Tuttnauer’s historic success, it’s no surprise that the company is not standing still but instead embarking on a journey of growth via acquisition. “Tuttnauer’s growth strategy has been consistent, whether it’s expanding into new markets to strengthen our global footprint or expanding our product portfolio via acquisitions,” Hagay elaborates. “Our acquisition strategy focuses on expanding our capabilities across the full sterilization and infection control workflow. In 2018, we made a strategic investment to partially acquire ATOS, an Italian manufacturing leader in washer-disinfectors, which enabled us to deliver a full sterilization solution of autoclaves washers for the healthcare and laboratory markets.
“The acquisition of Prestige Medical, a well-established UK distributor, in 2021, enhanced our direct reach across Europe. Also, the partial acquisition of E.C.S. further consolidated our position as a full-cycle sterilization partner, as this product portfolio includes packaging materials and chemical and biological indicators.”
Alongside acquisitions, Tuttnauer is also entering a phase Hagay describes as a ‘strong focus on manufacturing and supply chain excellence,’ spearheaded by the company’s new production facility in Hungary. “Last year, we opened a large state-of-the-art production facility in Hungary, which is staffed by an experienced team dedicated to producing our market-leading autoclave devices and distributing them worldwide. Opening this site was driven by a clear goal to significantly improve the logistics, availability, and delivery of both spare parts and finished products. This expansion strengthens our global responsiveness and elevates the overall customer experience.”
As our conversation draws to a close, talk turns to what the future holds for Tuttnauer. “Our top priority remains unchanged: staying deeply customer-focused and growing in true partnership with our customers,” Hagay says. “Since taking on the role of CEO, I’ve added new senior management to our exceptionally talented team to bring fresh perspectives to our operations. We are committed to strengthening our manufacturing capabilities, elevating our service, and delivering a better, more reliable experience to every customer. With our experienced team and new leadership members in place, I am confident that Tuttnauer is positioned for strong growth, both in the coming year and well into the future.
“In the next five years, I envision Tuttnauer significantly expanding its global presence, with a particular focus on strengthening our footprint in the European market. Also, with our renewed strategy, upgraded manufacturing capabilities, and expanded product lineup, we are well positioned to become a leading partner for clinics across the region.
“I also see Tuttnauer advancing its technology leadership through AI-driven solutions, enhanced connectivity, and smarter devices that elevate efficiency and reliability for every customer,” Hagay concludes. “Our goal is to be recognized not only for our century of expertise, but for shaping the future of sterilization and infection control.”